Complement activation in peritonitis. Association with hepatic and renal perfusion abnormalities. First place winner: Conrad Jobst award.
The authors have shown that systemic activation of the complement system with either zymosan or cobra venom factor produces some of the hemodynamic changes characteristic of sepsis, specifically, a reduction in hepatic perfusion despite a normal or hyperdynamic systemic circulation. This study was undertaken to determine whether complement activation accompanied reductions in effective hepatic and renal blood flow (EHBF and ERBF, respectively) in a septic murine model previously demonstrated to be associated with flow redistribution. Rats underwent either cecal ligation and puncture (CLP) or sham laparotomy after a baseline blood sample was collected for complement assay. Eighteen hours later, thermodilution cardiac output, mean arterial pressure, heart rate, hematocrit, EHBF by galactose clearance, and ERBF by p-aminohippurate (PAH) clearance were determined. A second blood sample was collected for measurement of total hemolytic complement (CH50) by immune hemolysis of sheep erythrocytes and was compared to the t = 0 sample for calculation of per cent change in CH50. The cardiac output and hematocrit were normal in the CLP group relative to sham. The septic animals were tachycardic and slightly hypotensive, suggesting a diminished systemic vascular resistance. EHBF and ERBF fell dramatically in the septic group despite the normal cardiac output. Residual hemolytic complement activity was reduced to less than 40% of preseptic levels in the CLP group while sham values were no different than baseline, indicating massive complement activation in the septic animals. This study demonstrates an association between complement activation and hepatic and renal perfusion abnormalities in murine peritonitis. Work is underway to establish the temporal relationship between complement activation and visceral flow changes.(ABSTRACT TRUNCATED AT 250 WORDS)
Department of Surgery, Veterans' Administration Medical Center, Cleveland, Ohio 44106.
W J
WJ
Schirmer
J M
JM
Schirmer
G B
GB
Naff
D E
DE
Fry
D000818:Animals; D003167:Complement Activation; D004546:Elapid Venoms / Q000494:pharmacology; D005260:Female; D008102:Liver Circulation; D008297:Male; D009102:Multiple Organ Failure / Q000503:physiopathology; D010538:Peritonitis / Q000276:immunology* / Q000503:physiopathology; D051381:Rats; D011919:Rats, Inbred Strains; D012079:Renal Circulation; D013997:Time Factors; D014655:Vascular Resistance; D015054:Zymosan / Q000494:pharmacology
D004546:Elapid Venoms; C016310:cobra venom factor; D015054:Zymosan